The long-range goal of this project is to elucidate the molecular mechanisms of expression and the role of the corneal Class 3 aldehyde dehydrogenase (ALDH3c; mouse AHD4). Studies in several mammalian species, including human, have revealed high AHD4 expression in cornea. Although this enzyme represents a major (10-40 percent) corneal soluble protein, its function and molecular mechanism(s) of expression in cornea remain unclear. It has been suggested that AHD4 might play a critical role in cornea by maintaining transparency and/or redox balance, facilitating absorption of UV light, and disposing of UV generated cytotoxic aldehydes. Genetic variants of AHD4 are known to exist in mice and humans. The SWR/J mouse strain, which exhibits a low AHD4 phenotype, shows extensive corneal clouding after UV exposure, compared with that in other mouse strains having high ocular AHD4 activity. They have cloned the AHD4 cDNA from SWR/J mouse cornea and found that this gene is indeed polymorphic. A correlation between the low AHD4 enzymatic activity phenotype and keratoconus (and other corneal pathology) has been reported in humans. They have previously cloned and sequenced the mouse Ahd4 gene. The principal investigator has recently identified the promoter and enhancer elements in a 3.2-kb 5' flanking region of this gene that are presumably involved in corneal expression. In order to elucidate the molecular mechanisms of the corneal AHD4 expression, as well as its protective role in the eye, they therefore propose to: 1) characterize cis-and/or trans-regulatory DNA elements responsible for cornea-specific Ahd4 gene expression. Ahd4 promoter/enhancer-luciferase DNA constructs will be used to transfect corneal epithelial cells lines available in their laboratory. in vitro footprinting and gel retardation assays will be used to characterize the cornea-specific DNA elements. 2) characterize the Ahd4 polymorphism in mice. To elucidate functional or structural differences in AHD4 protein variants, they will clone allelic cDNAs in expression vectors and express them in prokaryotic and human corneal cell lines. 3) develop a knockout mouse line having homozygous disruptions in the Ahd4 gene. These mouse lines will allow them to study the physiologic and protective role of corneal AHD4 against oxidative damage caused by UV irradiation. These studies will greatly enhance the understanding about the regulation and the role of the corneal Ahd4 gene. Because of conservation between human and mouse, and human polymorphisms in the ALDH3c gene are known to exist, these studies should help elucidate the Ahd4 gene as a genetic factor in the UVR-induced eye damage.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29EY011490-04
Application #
6329554
Study Section
Visual Sciences A Study Section (VISA)
Program Officer
Fisher, Richard S
Project Start
1997-12-01
Project End
2002-11-30
Budget Start
2000-12-01
Budget End
2001-11-30
Support Year
4
Fiscal Year
2001
Total Cost
$102,641
Indirect Cost
Name
University of Colorado Denver
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Rattray, Nicholas J W; Charkoftaki, Georgia; Rattray, Zahra et al. (2017) Environmental influences in the etiology of colorectal cancer: the premise of metabolomics. Curr Pharmacol Rep 3:114-125
Singh, Surendra; Arcaroli, John J; Orlicky, David J et al. (2016) Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma. Pancreas 45:117-22
Koppaka, Vindhya; Chen, Ying; Mehta, Gaurav et al. (2016) ALDH3A1 Plays a Functional Role in Maintenance of Corneal Epithelial Homeostasis. PLoS One 11:e0146433
Jackson, Brian C; Reigan, Philip; Miller, Bettina et al. (2015) Human ALDH1B1 polymorphisms may affect the metabolism of acetaldehyde and all-trans retinaldehyde--in vitro studies and computational modeling. Pharm Res 32:1648-62
Singh, S; Arcaroli, J; Thompson, D C et al. (2015) Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers. Adv Exp Med Biol 815:281-94
Jang, Jun-Ho; Bruse, Shannon; Liu, Yushi et al. (2014) Aldehyde dehydrogenase 3A1 protects airway epithelial cells from cigarette smoke-induced DNA damage and cytotoxicity. Free Radic Biol Med 68:80-6
Monte, Andrew A; Heard, Kennon J; Campbell, Jenny et al. (2014) The effect of CYP2D6 drug-drug interactions on hydrocodone effectiveness. Acad Emerg Med 21:879-85
Chen, Ying; Thompson, David C; Koppaka, Vindhya et al. (2013) Ocular aldehyde dehydrogenases: protection against ultraviolet damage and maintenance of transparency for vision. Prog Retin Eye Res 33:28-39
Vasiliou, Vasilis; Sandoval, Monica; Backos, Donald S et al. (2013) ALDH16A1 is a novel non-catalytic enzyme that may be involved in the etiology of gout via protein-protein interactions with HPRT1. Chem Biol Interact 202:22-31
Vasiliou, Vasilis; Thompson, David C; Smith, Clay et al. (2013) Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. Chem Biol Interact 202:2-10

Showing the most recent 10 out of 42 publications